Physical Activity and Sedentary Behavior During Pregnancy
PREGMOUV
Care Pathway Organization in Order to Increase Physical Activity Levels and Limit Sedentary Behavior During Pregnancy: a Randomized Controlled Trial
2 other identifiers
interventional
630
1 country
1
Brief Summary
Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA). Our hypothesis is that identifying types of interventions suitable for pregnant women (in-person PA sessions, videoconferences or mixed format) could help improve their PA level and simultaneously reduce their sedentary behavior (SB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
September 5, 2024
CompletedStudy Start
First participant enrolled
September 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
September 24, 2024
September 1, 2024
3.1 years
August 26, 2024
September 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Women's adherence to PA at the end of the second trimester
measurement of the PA level, measured by accelerometer, expressed in MET.minutes/week by wearing a tri-axial accelerometer on the hip
between 24 and 30 weeks of gestation
Secondary Outcomes (35)
women's adherence in terms of reduction of Sedentary Behaviors at the end of the 2nd trimester
between 24 and 30 weeks of gestation
Women's participation at PA sessions
After 39 weeks of gestation, end of planned participation in sessions
Pregnancy and Postpartum Evolution of PA Time
at 4 distinct times: between 24+0d and 30+0d weeks of gestation, between 32+0d and 37+6d weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
Evolution in sedentary behavior during pregnancy and postpartum
at 4 distinct times: between 24 and 30 weeks of gestation, between 32+0day and 37+6day weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
Women's perception of the determinants of their level of physical activity and sedentary behaviour
during the 31 days after at the inclusion in the study and between 35 and 39 weeks of gestation
- +30 more secondary outcomes
Study Arms (4)
A - Free PA practice
NO INTERVENTIONThe women in group A (control group) will receive the usual care provided for any pregnancy, i.e. personalised information on physical activity and sedentary behaviour, with the provision of information booklets. They will be free to exercise during their pregnancy
B
EXPERIMENTALIn-person supervised PA sessions
C
EXPERIMENTALInteractive videoconference PA sessions
D
EXPERIMENTALIn person and by videoconference (mixed format) PA sessions
Interventions
Group B women will have access to a weekly program of 3 face-to-face PA sessions. The face-to-face sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. They will also be offered at one or more times depending on the number of groups. Locations and times will be specified on the online booking software. Women can only register for 3 sessions per week.
Women in Group C will have access to a weekly program of 3 PA sessions via interactive videoconferencing. These sessions will have the same format as the face-to-face sessions with visualization of the APA professional, visualization of the participants (who can also choose to be masked). The PA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 3 sessions per week.
Women in Group D will have access to a weekly program of 3 mixed-format PA sessions, with 2 interactive distance learning sessions and 1 in-person session. The in-person sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. Locations and times will be specified on the online booking software. Women can only register for 1 face-to-face session per week. The other 2 sessions will be offered via interactive videoconferencing. These sessions will have the same format as the in-person sessions, with visualization of the APA professional, visualization of the participants. The APA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 2 videoconference's sessions per week.
Eligibility Criteria
You may qualify if:
- Pregnant women of more of 18 years and who are being monitored for pregnancy in the Clermont-Ferrand metropolitan area,
- Planned to give birth in a maternity unit localized in Clermont-Ferrand metropolitan area (CHU Estaing or Clinique de la Chataigneraie),
- Agreeing to be randomized, to follow the physical activity program offered in the Clermont-Ferrand metropolitan area, and to follow up as part of the study,
- Able to give informed consent to participate in the research,
- Affiliated to a social security scheme
- And between 14+0d and 21+6d weeks of gestation.
- Women under guardianship, curators, deprived of liberty or under court protection,
- With a history of recurrent miscarriage,
- Presenting a multiple pregnancy,
- Hemoglobinemia \<9g/dL or symptomatic anemia,
- Presenting eating disorders or a BMI ≤ 18.5 or a BMI ≥ 40,
- With orthopedic limitations,
- Presenting cardiovascular or pulmonary disease,
- Uncontrolled thyroid disease,
- Presenting a high level of smoking,
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Clermont-Ferrandlead
- Réseau de Santé en Périnatalité d'Auvergnecollaborator
- ASM Omnisports - Pôle Sport-Santécollaborator
- Office Municipal du Sport - Espace Sport Santécollaborator
- Observatoire national de l'activité physique et de la sédentaritécollaborator
- Ville de Clermont-Ferrandcollaborator
- Ministère de la Santé et de la Préventioncollaborator
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chloé BARASINSKI
CHU de Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2024
First Posted
September 5, 2024
Study Start
September 10, 2024
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share